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Mammary extracellular matrix 
directs differentiation of testicular 
and embryonic stem cells to form 
functional mammary glands in vivo
Robert D. Bruno1,*, Jodie M. Fleming2,*, Andrea L. George3, Corinne A. Boulanger3, 
Pepper Schedin4 & Gilbert H. Smith3
Previously, we demonstrated the ability of the normal mammary microenvironment (niche) to direct 
non-mammary cells including testicular and embryonic stem cells (ESCs) to adopt a mammary epithelial 
cell (MEC) fate. These studies relied upon the interaction of transplanted normal MECs with non-
mammary cells within the mammary fat-pads of recipient mice that had their endogenous epithelium 
removed. Here, we tested whether acellular mammary extracellular matrix (mECM) preparations are 
sufficient to direct differentiation of testicular-derived cells and ESCs to form functional mammary 
epithelial trees in vivo. We found that mECMs isolated from adult mice and rats were sufficient to 
redirect testicular derived cells to produce normal mammary epithelial trees within epithelial divested 
mouse mammary fat-pads. Conversely, ECMs isolated from omental fat and lung did not redirect 
testicular cells to a MEC fate, indicating the necessity of tissue specific components of the mECM. 
mECM preparations also completely inhibited teratoma formation from ESC inoculations. Further, a 
phenotypically normal ductal outgrowth resulted from a single inoculation of ESCs and mECM. To the 
best of our knowledge, this is the first demonstration of a tissue specific ECM driving differentiation of 
cells to form a functional tissue in vivo.
Understanding the microenvironmental factors that control cell function, differentiation, and stem cell renewal 
are at the crux of developmental and cancer biology. In recent years, our laboratory has explored the capacity of 
the local mammary microenvironment (niche) to control the cellular fate and differential potential of cells1–9. 
Our previous reports have found that the regenerating mouse mammary gland can re-direct testicular cells1, 
neural stem cells2, bone marrow5, and breast cancer cells3,4 to adopt a normal mammary progenitor cell fate. 
Further, we found that the mammary microenvironment can suppress teratoma formation and direct differentia-
tion of mouse embryonic stem cells (ESCs)7 and human teratocarcinoma (Ntera-2) cells3 to a mammary epithelial 
cell fate in vivo. In all cases, the redirected non-mammary or cancer-derived cell types continued to proliferate 
and self-renew, persisting through multiple transplant generations. All of these studies were performed with 
essentially the same experimental design: dispersed normal mouse mammary epithelial cells were mixed with 
non-mammary or cancer cells and inoculated into the cleared mammary fat-pad of a recipient mouse. Our inter-
pretation of this is that the non-mammary and cancer-derived cells are incorporated into mammary niches, due 
to cell-cell interaction, as these locations are formed by the dispersed MECs during growth. Once incorporated, 
they adopt a normal mammary cell fate and contribute mammary progeny to the outgrowth. These studies under-
score the dominance of the mammary locale (niche) in determining cell fate in the mammary gland. However, the 
nature and composition of the mammary niche(s) remains elusive.
The extracellular matrix (ECM) is a key component of the cellular microenvironment. More than just 
a scaffold of support proteins, the ECM is tethered with diverse signaling molecules that show tissue-specific 
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patterning10,11. In the mammary gland, the ECM is dynamic, changing in both composition and structure with 
pregnancy, lactation, and involution12. ECM has a role in stem cell renewal and differentiation both in vivo and 
in vitro, and thus is likely an important mediator of the mammary stem cell niche.
Here, we tested the hypothesis that mammary ECM contains factors that are integral components of the 
mammary niche and thus sufficient to direct differentiation of non-mammary cells in the context of the mam-
mary fat-pad. Specifically, we tested if mammary ECM (mECM) extracts would be sufficient (in the absence of 
normal MECs) to direct the differentiation of testicular and ESCs to MECs when transplanted into a cleared 
mammary fat-pad. Testicular cells were sourced from WAP-CRE/Rosa26-loxp-stop-loxp-LacZ (WC/R26LacZ)13. 
These mice have been previously described to mark a particular progenitor population termed parity identified 
mammary epithelial cells (PI-MECs) following pregnancy and involution6,14–16. Briefly, activation of the whey 
acidic protein (WAP) promoter during pregnancy induces CRE expression which in turn removes a premature 
floxed stop-codon causing irreversible and constitutive β -galactosidase (β -gal) expression from the Rosa26-LacZ 
locus. PI-MECs are found among a fraction of luminal cells within secondary and tertiary ducts, and function 
as lobular progenitors in subsequent pregnancies14,15. The ESCs used here were isolated from Rosa26-LacZ mice, 
and constitutively express β -gal in all cell types17,18. These two reporters allowed us to identify the exogenous cell 
sources in resulting transplants by 5-bromo-4-chloro-3-indolyl-β -D-galactopyranoside (X-gal) staining. mECM 
was isolated from mammary glands of adult female nulliparous mice, as well as nulliparous and involuting rats. 
We identified X-gal+ outgrowths in a total of 26/99 mammary glands inoculated with testicular cells and mECM 
across all conditions. The outgrowths displayed normal mammary gland morphology and milk protein produc-
tion. Conversely, ECM from omental fat or lung were incapable of directing testicular cells to form mammary 
outgrowths. We also found that mECM eliminated teratoma formation of ESCs and resulted in an X-gal+ out-
growth in a single case. The resulting outgrowth demonstrated cytokeratin and hormone receptor expression. 
These results demonstrate that the non-cellular mECM fraction of the mammary gland contains critical factors 
of the mammary niche that, in conjunction with the mammary fat-pad, are sufficient to direct non-mammary 
cells to a mammary epithelial cell fate. These findings are, to the best of our knowledge, the first demonstration of 
the capacity of adult tissue specific ECM to mediate the direct differentiation of stem cells and inhibit teratoma 
formation in vivo.
Results
Mouse mammary ECM (mECM) redirects testicular cells to adopt a normal mammary epithelial 
cell fate. Cells isolated from the testes of WC/R26Lacz mice were the first to be shown to respond to signals 
within the regenerating mouse mammary gland to adopt a normal mammary epithelial progenitor cell fate1. 
To advance these findings, we tested whether physical contact with mammary epithelial cells was required, or 
whether the soluble and structural constituents of the mECM were sufficient to redirect testicular cells to a mam-
mary epithelial cell fate. 7.5 × 104 mouse testicular cells were injected with or without soluble mECM isolated 
from adult nulliparous female BALB/c mice into the cleared mammary fat pads of recipient female nude mice. 
Following pregnancy and involution, whole mount and cross-section imaging of mammary glands revealed nor-
mal X-gal+ mammary epithelial outgrowths in 16/62 inoculations with mECM (Table 1; Fig. 1A–D). Importantly, 
the pattern of X-gal staining was consistent with the expected distribution of PI-MECs in intact WC/R26-LacZ, 
suggesting normal activation of the Wap promoter. Consistent with previous results1, inoculations of testicular 
cells in vehicle (DMEM) did not generate mammary outgrowths (0/15; Table 1). Further, no Xgal+ outgrowths 
were observed when testicular cells were inoculated with matrigel (not shown) or with ECM isolated from omen-
tal fat (0/14) or lungs (0/19) of adult mice (Table 1). The difference in rate of outgrowth formation between inoc-
ulations of testicular cells with mECM or with omental fat ECM, lung ECM or vehicle (DMEM) was statistically 
significant (p = 0.0327; p = 0.0173, and p = 0.0326, respectively). Therefore, the factors critical for the differenti-
ation of the testicular cells to MECs are specific to mECM. We identified the presence of the Y chromosome by 
fluorescent in situ hybridization (FISH) and PCR in the outgrowths, confirming they were derived from the tes-
ticular cells and not ingrowth of endogenous epithelium (Fig. 1E and F). Furthermore, inoculations of the cleared 
fat pads with mECM alone did not induce outgrowths (0/10; Table 1) or notable changes to the adipose/stroma.
It is important to note that positive X-gal staining under these experimental conditions is only seen in the 
mammary gland upon exogenous expression of β -gal13,19. Exogenous β -gal expression could only come from the 
transplanted testicular cells. Further, to express β -gal, the testicular cells must have activated the mammary spe-
cific WAP promoter during pregnancy and subsequently survived involution. This is consistent with the interpre-
tation that the testicular derived cells had differentiated into fully functional mammary epithelial cells including 
PI-MECs.
To determine if the testicular-derived epithelial trees were capable of normal MEC function, fragments taken 
from first generation outgrowths were transplanted into cleared mammary fat pads of new hosts and the mice 
were mated to induce lactogenic differentiation. At 14 days of pregnancy, glands were removed and cross sec-
tioned. Staining with antibodies specific for the milk proteins alpha-lactalbumin and caseins revealed normal 
milk protein production and luminal secretion, consistent with normal mammary epithelial cell function (Fig. 1G 
and H). The glands also expressed the basal myoepithelial cell marker smooth muscle actin alpha (SMA; Fig. 1I) 
and the hormone receptor ERalpha (ERα ; Fig. 1J) in the correct orientations. Combined, these results demon-
strate that the testicular derived cells had made a fully functional mammary epithelial tree upon transplantation 
with mECM.
mECM from both nulliparous and involuting rats redirect testicular cells to adopt a normal 
mammary epithelial cell fate. Following these initial observations, we next turned to mECM isolated 
from Sprague-Dawley rat mammary tissues. Rat mammary epithelial cells grow normally in mouse fat pads and 
mouse cells respond to rat mECM12,20. Rat tissue is advantageous because of the greater concentrations of mECM 
www.nature.com/scientificreports/
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that can be produced from the larger rat glands. 5 × 104 WC/R26-LacZ mouse testicular cells were injected with 
or without soluble mECM from nulliparous or involuting female rats into the cleared mammary fat-pad of nude 
recipient female nude mice. As previously reported1, 5 × 104 testicular cells never formed glands when inocu-
lated alone (0/20; Table 1). Both nulliparous ECM and involuting ECM preparations were used because previous 
studies have identified differences in their content and stimulatory effects on breast cancer cells21,22. Following 
pregnancy and involution, whole mount and cross-section imaging of mammary glands revealed normal X-gal+ 
mammary epithelial outgrowths in 4/18 inoculations with nulliparous mECM (p = 0.0415 vs testicular cells 
alone) and 6/19 inoculations with involuting mECM (p = 0.0083 vs. testicular cells alone; Fig. 2; Table 1). There 
was no statistical difference in the effect of involuting mECM vs nulliparous mECM (p = 0.7140).
An important feature of the mouse mammary gland is the capacity of any portion of the epithelial tree to 
regenerate a functional mammary tree upon transplantation23. To determine if the testicular/mECM derived 
outgrowths retained this capacity, we transplanted fragments from first-generation outgrowths resulting from 
inoculation of testicular cells and nulliparous mECM into cleared mammary fat-pads and stained the resulting 
glands with X-gal. 5/8 transplants resulted in mammary outgrowths that contained X-gal+ cells, with the remain-
ing 3 not forming any outgrowth (Fig. 2I and J; Table 1). This is consistent with previous results that demon-
strated that non-mammary cells redirected to a MEC fate by the mammary microenvironment could contribute 
to second-generation outgrowths2,5,7,16. Presence of the X-gal+ cells in second generation outgrowths demon-
strates that the β -gal+ testicular derived cells were not terminally differentiated, but capable of self-renewing and 
undergoing extensive proliferation to regenerate the gland.
Mammary ECM extracts inhibit teratoma formation and direct differentiation of mouse ES 
cells to mammary epithelial cells in cleared mammary fat-pads. We next sought to determine if 
pluripotent ESCs could similarly be directed to a MEC fate by inoculation with mECM into cleared mammary 
fat-pads. We injected 1 × 103 or 1 × 104 Rosa26-LacZ ESCs (which constitutively express β -gal) with or without 
involuting ECM. As previously reported7, Rosa26-LacZ ESCs formed teratomas in all cases when inoculated 
in vehicle (DMEM) alone (Table 2). However, in the presence of mECM, none of the ESC inoculations formed 
teratomas (Table 2). This reduction in teratoma formation by mECM is statistically significant (p = 0.0079) for 
both cell injection numbers (1 × 103 and 1 × 104). Further, 1/5 inoculations of 1 × 103 Rosa26-LacZ ESCs formed 
a mammary epithelial outgrowth that stained positive for X-gal (Fig. 3A). Cross sections demonstrated that the 
Xgal+ cells were present throughout the ductal tree in nearly all cells (Fig. 3B and C), as expected for the consti-
tutive Rosa26-LacZ reporter.
To further verify the mammary epithelial tree consisted of the transplanted Rosa26-LacZ ESCs and did not 
result from ingrowth of endogenous cells, we performed PCR on DNA isolated from the outgrowth to detect the 
Rosa26-LacZ locus (Fig. 3D). Primers specific for the Rosa26-LacZ locus amplified DNA in the X-gal positive 
outgrowth shown in Fig. 3A but not in control mouse glands. Further, primer sets specific for rat DNA confirmed 
no contamination of rat MECs within the mECM.
Finally, we immunostained the resulting mammary outgrowth to determine if the ESCs had differentiated into 
all the major epithelial cell types of the mammary gland. The outgrowth stained positive with a pan-cytokeratin 
antibody (Fig. 4A and B) although the staining lacked uniformity as usually seen in normal mammary tissues 
(Fig. 4C). Similarly, staining with an antibody specific for the luminal marker cytokeratin 8 (Fig. 4D and E) 
demonstrated the presence of CK8 cells with a lack of uniformity compared to control glands (Fig. 4F). 
Conversely, normal staining confined to the basal layer was seen with the basal marker SMA (Fig. 4G). Further, 
ERα and progesterone receptor (PR) positive and negative cells were seen throughout the luminal layer of the 
ESC-derived gland (Fig. 4H and I). The reason for the punctate staining pattern of the cytokeratins is unknown. 
It could either be a result of incomplete differentiation of some of the ESC-derived cells or an artifact of the 
sample preparation. The normal staining seen in a control sample within the same block argues against the latter 
interpretation, however. Regardless, these results demonstrate that the Rosa26-LacZ derived ESCs were capable 
Cell Source Treatment
Xgal+ mammary outgrowth/
total inoculations
Xgal+ second generation 
outgrowths inoculations
7.5 × 104 Testicular Cells Nulliparous Mouse mECM 16/62 ND
7.5 × 104 Testicular Cells Omental Fat ECM 0/14 N/A
7.5 × 104 Testicular Cells Lung ECM 0/19 N/A
7.5 × 104 Testicular Cells DMEM 0/15 N/A
None Nulliparous Mouse mECM 0/10 N/A
5 × 104 Testicular Cells Nulliparous Rat mECM 4/18 5/8
5 × 104 Testicular Cells Involuting Rat mECM 6/19 ND
5 × 104 Testicular Cells DMEM 0/20 N/A
Table 1.  Transplantation results for WC/R26-LacZ testicular cells with mECM. Cell/ECM mixtures were 
inoculated into the epithelium divested (cleared) mammary fat-pads of 3–4 week old female nude mice. Mice 
were impregnated and allowed to involute for 3 weeks to activate the WC/R26-LacZ reporter. Second generation 
outgrowths were generated by transplanting fragments from Xgal+ primary outgrowths into cleared mammary 
fat-pads of 3–4 week female nude old mice and allowed to grow for 8 weeks. ND = not determined; N/A = not 
applicable.
www.nature.com/scientificreports/
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of differentiating into all of the major mammary epithelial cell types when injected along with mammary ECM 
into the cleared mammary fat-pad.
Discussion
While a great deal of focus has been paid to the identification and characterization of somatic cells with stem cell 
characteristics, we continue to lack a basic understanding of how heterogenous lineages of cells are generated 
and maintained in vivo. Our recent work has demonstrated that in the mammary gland, the components of the 
microenvironment (i.e. niche) are the ultimate determinant of cell function, regardless of the original nature of 
the stem/progenitor cells within the system. Here we extend these observations by demonstrating that the acellu-
lar mECM fraction of the gland contains key components of the niche that are sufficient to direct differentiation 
of non-mammary cells to a MEC fate in the context of the mammary fat-pad in vivo. In the case of the testicular 
derived cells, they had all of the attributes associated with normal MECs, including the capacity to make milk pro-
teins (Fig. 1G and H) and persist through second-generation outgrowths (Fig. 2I and J). This is important because 
it demonstrates the signaling effect of the mECM is not to terminally differentiate the cells, but rather assist in 
the organization of the cells into fully functional mammary niches, capable of supporting all aspects of gland 
development and function. One important distinction between the present study and our previous publications 
is that the non-mammary cells were able to differentiate and form the entire functional mammary gland without 
Figure 1. Testicular cells form normal mammary outgrowths in vivo when transplanted with mouse mECM. 
7.5 × 104 testicular cells derived from WC/R26-LacZ mice were inoculated in suspensions of mECM, omental fat 
ECM, lung ECM, or vehicle (DMEM) into cleared mammary fat-pads of female nude mice. Following full-term 
pregnancy and 3 weeks of involution to activate the WC/R26-LacZ reporter in the testicular-derived cells, glands 
were isolated for analysis. (A–C) Examples of X-gal+ whole mounts from inoculations of testicular cells and 
mECM. X-gal+ outgrowths were not seen in any of the testicular cells + control (omental fat ECM, lung ECM, and 
DMEM) groups. (D) Cross-section of a an X-gal stained gland derived from testicular cells. X-gal stain is blue, 
nuclei are counterstained with nuclear fast red. (E) FISH analysis of testicular derived outgrowths with probes to 
the X-chromosome (magenta; left panel) and Y chromosome (green, right panel). (F) PCR with primers specific 
for the Y chromosome. Lane 1: Molecular weight marker; Lane 2, 4, and 5: Testicular cells + mECM outgrowth; 
Lane 3: Testicular cells + mECM inoculated fat pad with no outgrowth; Lane 6: water; Lane 7&8: MEC + mECM 
outgrowths; Lane 9&11: outgrowth derived from MEC + testicular cells; Lane 10: MEC + testicular cell inoculated 
fat pad with no outgrowth; Lane 12: MEC cells; Lane 13: Testicular cells. (G–J) IHC staining for alpha-lactalbumin 
(G), caseins (H), smooth muscle actin (I), and ERα (J) in outgrowth of testicular cells and mECM in 14 day 
pregnant host (nuclei counterstained with haematoxylin). Scale bars: A–C = 2 mm; D = 200 μ M; E = 100 μ M; G-
I = 100 μ M; J = 200 μ M.
www.nature.com/scientificreports/
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Figure 2. Testicular cells are directed to MECs by both nulliparous and involuting rat mECM in vivo. 
5.0 × 104 testicular cells from WC/R26-LacZ mice were inoculated in suspensions of nulliparous rat mECM, 
involuting rat mECM, or vehicle (DMEM) into cleared mammary fat-pads of female nude mice. Following  
full-term pregnancy and 3 weeks of involution to activate the WC/R26-LacZ reporter in the testicular-derived 
cells, glands were isolated for analysis. (A–D) X-gal stained whole mounts (A and C) and cross-sections  
(B and D) of mammary outgrowths derived from testicular cells and nulliparous rat mECM. (E–H) X-gal 
stained whole mounts (E and G) and cross-sections (F and H) of mammary outgrowths derived from testicular 
cells and involuting rat mECM. (I and J) X-gal stained whole mount (I) and cross-section (J) of second-
generation outgrowth derived from transplantation of tissue fragments of primary outgrowths of testicular cells 
and nulliparous mECM. X-gal+ stain is blue. All cross-sections are counterstained with nuclear fast-red. Scale 
Bars: A,C,E,G and I = 2 mm; B,D,F, and H = 200 μ M; J = 400 μ M.
www.nature.com/scientificreports/
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assistance from bona fide MECs. This in itself is remarkable because it indicates that all the signals necessary to 
form a functional mammary epithelium in a competent mammary fat-pad are present in the “ECM’ preparations 
from intact mammary glands.
The other major finding of this work is that mECM from involuting mammary glands significantly reduced 
teratoma formation by the ESCs (Table 2). In fact, under our conditions, teratoma formation was completely elim-
inated. This is in contrast to previous publications demonstrating pro-tumorigenic affects of involuting mECM 
on breast cancer cells22. This difference may be due to differential effects of mECM on pluripotent ESCs versus 
breast cancer cells, with the former potentially responding by differentiation and/or apoptosis to the presence 
of the mECM. It should be noted, no evidence of differentiation of ESCs—that is presence of X-gal+ cells—was 
seen in the fat-pads of the nine inoculations that did not form teratomas or mammary outgrowths. This suggests 
that the ESCs had not survived the 12 weeks in vivo. However, the presence of a small amount of ESCs cannot be 
ruled out.
The mechanism(s) by which mECM mediates the suppression of teratoma formation and the differentiation 
of testicular and ESCs to mammary epithelial cells is currently unknown. Two possibilities exist: 1. The mECM 
directly induces the differentiation of the non-mammary cells to MECs, which in turn communicate with the 
stromal fat-pad environment to develop into a mammary epithelial tree; 2. The mECM activates signaling within 
the stromal fat-pad environment to produce signals that direct the differentiation of the non-mammary cells to 
differentiate to MECs. The latter is more likely, but future studies should determine the direct effects of mECM 
on both the non-mammary cells (outside of the mammary fat-pad) and the stromal cells within the mammary 
fat-pad. Further, specific components of the mECM preparations should be evaluated to determine the critical 
elements of the mECM. Because the low frequency of gland formation with both testicular and ESC inoculations 
Cell Source Treatment
Xgal+ mammary outgrowth/
total inoculations
Teratoma/total 
inoculations
1 × 103 ESCs Involuting Rat mECM 1/5 0/5
1 × 103 ESCs DMEM 0/4 4/4
1 × 104 ESCs Involuting Rat mECM 0/5 0/5
1 × 104 ESCs DMEM 0/4 4/4
Table 2.  Transplantation results for R26-LacZ ESCs with mECM. Cell/ECM mixtures were inoculated into 
the epithelium divested (cleared) mammary fat-pads of 3–4 week old female nude mice. Glands were allowed 
to grow for 12 weeks. Differences in teratoma formation rates between mECM and vehicle (DMEM) treatments 
were significant (p = 0.0079) for both cell injection numbers (1 × 103 and 1 × 104).
Figure 3. Normal mammary outgrowth derived from ESCs and involuting rat mECM. In 1/5 inoculations of 
1 × 103 R26-LacZ ESCs and involuting rat mECM a morphologically normal x-gal+ mammary outgrowth was 
observed. (A–C) X-gal+ whole mount (A) and cross-sections (B and C) of ESC-derived mammary outgrowth. 
(D) PCR analysis using primers specific for LacZ gene, rat actin, and mouse chromosome 1 (positive control) in 
the outgrowth shown in A–C. Lane 1 = R26-LacZ mouse tail DNA; Lane 2: WT Balb/c mouse tail DNA; Lane 3: 
ESC + ECM outgrowth DNA; Lane 4: Water; Lane 5: WT Balb/c mouse tail DNA; Lane 6: Rat LA-7 cell DNA; 
Lane 7: ESC + mECM outgrowth DNA; Lane 8: Water. Results confirm outgrowth is comprised of R26-LacZ 
mouse ESC-derived cells. Scale Bars: A = 1.5 mm; B = 100 μ m; C = 200 μ m.
www.nature.com/scientificreports/
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with the soluble mECM preparations used, future studies should also evaluate the effect of different mECM 
preparations (e.g. pepsin digestion) that result in differential protein compositions and structures. Future studies 
might also evaluate the effect of different mECM preparations after pretreatment with proteases or nucleases to 
help evaluate the nature of the active substances.
Given the wealth of literature showing the unique proteinaceous composition of the mammary ECM, which 
also alters during distinct developmental stages12,20,24–28, pinpointing the exact molecules and the orchestration of 
signaling between the stroma and parenchyma to direct cell behavior is a challenge. ECM isolated from nullipa-
rous rats has been shown to promote the formation of epithelial ducts with bifurcation, while matrix isolated from 
mid-involuting mammary glands induced cell death. ECM isolated from late-stage involuting glands restored 
glandular development, and ECM isolated from parous animals restricted glandular morphogenesis12. Our stud-
ies support this work by demonstrating both nulliparous and late-stage involuting ECM promote growth and 
reprogramming of testicular and embryonic cells to mammary epithelial cells. Collectively, these studies highlight 
that hormones, cytokines, and growth factors all influence ECM composition including collagen organization and 
stiffness, to affect mammary cell behaviors such as organization and function of integrins and the expression of 
cell-cell junction proteins and matrix metalloproteinases25. Critical to data presented within, recent studies sug-
gest that it is not individual molecules, but the relative abundance and organization of the ECM molecules that 
dictate tissue function and regulation of cell fate. For example, Goddard et al. demonstrated that the mammary 
gland and liver have the same ECM components, but distinct abundance and relative composition of individual 
protein components28. Ultimately, both mechanical and biochemical aspects of the soluble and insoluble ECM 
must be integrated to understand the collective function. Therefore, the mechanism(s) governing ECM medi-
ated control over cell fate determination are likely to be complex, and not governed by single “magic bullet” 
components.
Regardless of the mechanism(s), these findings have potentially major implications for our understanding of 
stem cell biology, cancer biology, and regenerative medicine. The mammary niche is composed of both mammary 
epithelial cells and the stromal microenvironment of the mammary fat-pad9,23. Together, this niche is sufficient to 
direct fate determination of non-mammary and cancer cells to make a functional mammary epithelial tree. The 
results outlined here demonstrate that the mECM is a key mediator of the niche. The experimental protocol can 
be used to test individual components of the mammary niche and shed light on mediators of normal development 
and cancer. Finally, the ability to of the mECM to reduce teratoma formation and potentially direct differentiation 
Figure 4. Expression of MEC proteins in ESC-derived mammary outgrowth. (A–C) Cross-sections of ESC-
derived outgrowth (A and B) and control gland (C) were stained with a an an anti-pan-cytokeratin antibody. 
(D–F) Cross-sections of ESC-derived outgrowth (D and E) and control gland (F) were stained with an anti-
cytokeratin 8 antibody. (G–I) ESC derived mammary outgrowth stained with an anti-SMA (G), anti-ERα (H), 
and anti-progesterone receptor (I). X-gal stain is seen in blue. Sections are counterstained with haematoxylin. 
Scale bars: A, D, and G = 200 μ M; B,C,E,F,H and I = 100 μ M.
www.nature.com/scientificreports/
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of pluripotent cells could benefit regenerative medicine applications, particularly to mitigate fears of teratoma 
formation in clinical applications.
These studies demonstrate that mammary epithelial cells are dispensable for the redirection of non-mammary 
cells to adopt a MEC fate in vivo. Further, the signaling required to redirect testicular cells to a MEC fate are 
specific to mECM, as ECM isolated from omental fat or lung failed to mediate lineage conversion. To our col-
lective knowledge, this is the first demonstration that cell fate may be altered in vivo by tissue specific ECM. The 
significance of this observation is that it opens the possibility of altering cell fate decisions in vivo without the use 
of cells or chemicals and has an important potential role in the control and prophylaxis of mammalian cancers 
in situ. The results allow for mechanistic dissection of key elements of the mammary microenvironment and 
have important implications for our understanding of developmental biology, cancer, and regenerative medicine.
Methods
Animal Models. All methods were performed in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals. The National Cancer Institute (NCI) Animal Care and Use Committee approved all exper-
imental procedures. Mature BALB/c and Sprague Dawley rats were used as donor mice to obtain ECM extracts. 
Female, 3-week-old athymic Nu/Nu mice were used as hosts for transplant studies (NCI Animal production area; 
Frederick, MD).
Cell Isolation. Testicular cells were isolated from adult male WAP-CRE/Rosa26-loxp-stop-loxp-LacZ (WC/
R26LacZ) mice as previously described1,8. Isolated testicular cells were inoculated immediately following isola-
tion. Cells were counted by hemacytometer and diluted in appropriate volumes of either soluble mammary ECM 
or plain Dulbecco’s Modified Eagle Medium (DMEM).
ESCs isolated from the Rosa26-LacZ mouse were a kind gift from Philipe Soriano17,18. Cells were cultured as 
previously described 7. For all experiments, frozen vials of ESCs were rapidly thawed immediately before inocu-
lation in vivo.
ECM Isolation. Acellular extracts were performed as described previously12. Briefly, mice/rats 
were euthanized and the desired tissues were immediately removed, pulverized and extracted with a 
high-salt/N-ethylmaleimide solution [3.4 M NaCl, 50 mM Tris-HCl (pH 7.4), 4 mM EDTA-Na2, and 2 mM 
N-ethylmaleimide] containing a protease inhibitor cocktail at 4 °C. Homogenates were pelleted at RCFmax 
110,000× g for 30 min at 4 °C, and then washed three times in the high salt buffer. The ECM-enriched pellets 
were resuspended in a mid-level salt/urea solution [2.25 M urea, 0.2 M NaCl, 50 mM Tris-HCl (pH 7.4), 4 mM 
EDTA-Na2, and 2 mM N-ethylmaleimide] with protease inhibitors and extracted overnight at 4 °C. Samples were 
pelleted at RCFmax 17,000× g, and the ECM-enriched supernatants were extensively dialyzed (Mr 12,000–14,000 
molecular weight cutoff; Spectrum) against a low-salt buffer [0.15 M NaCl, 50 mM Tris-HCl (pH 7.4), and 4 mM 
EDTA-Na2], followed by dialysis against serum-free DMEM:F-12 media supplemented with 1 μ g/ml gentamicin 
at 4 °C. Protein content was measured via Bradford assay. Samples were standardized to equal protein concentra-
tions (mouse ECM = 100 μ g/ml; Rat mECM = 300 μ g/ml).
Mammary fat-pad clearing and cell inoculation. Mammary fat pad clearing was performed on female 
nude mice between 3 and 4 weeks of age as previously described1,7,29,30. Briefly, mice were anesthetized and endog-
enous epithelium was removed from the #4 and #9 inguinal fat pads by surgically excision of the proximal por-
tion (from the nipple to the lymph node) of the gland. 5 × 104 or 7.5 × 104 freshly isolated testicular cells were 
then inoculated in 10 μ l of ECM or plain DMEM (control) into the cleared mammary fat-pad using a Hamilton 
syringe. After staples were removed 2 weeks post-operation, the recipient mice were mated to activate the WC/
R26-LacZ reporter. Following parturition, the pups were euthanized and the mice were allowed to involute for 3 
weeks prior to collection of the glands. For ESC transplants, 1 × 103 or 1 × 104 R26-LacZ ESCs were inoculated 
into cleared mammary fat-pads as described above for testicular cells. Glands were removed after 12 weeks (with-
out mating). All glands were then excised and fixed in 4.0% paraformaldehyde for 2 hrs prior to X-gal staining. 
Outgrowth and tumor formation rates were compared statistically by Fisher’s Exact Test.
X-Gal Staining and Immunohistochemistry. X-gal staining and whole mounting of mammary glands 
was carried out as previously described1,7,13. #3 and #8 thoracic glands from the recipient nude mice were used 
as negative staining controls for all X-gal staining procedures. X-gal-stained whole mounts were embedded in 
paraffin, sectioned at 6.0 μ m, and counterstained with nuclear fast red (Sigma-Aldrich, St Louis, MO, USA). 
Primary antibodies used were rabbit-anti-Cytokeratin 8 (ab53280 1:100; Abcam, Cambridge, MA, USA), 
rabbit-anti-keratin wide spectrum (Z0622 1:500; Dako, Carpinteria, CA, USA), rabbit-anti-ER alpha (sc-542 1:75; 
Santa Cruz Biotechnology, USA), rabbit-anti-progesterone receptor (A0098 1:150; Dako), and mouse-anti-SMA 
1A4 (1:100; Life Technologies, Carlsbad, CA, USA), anti-alpha-lactalbumin31 and anti-caseins32. IHC staining 
procedure was carried out using the RTU Vectastain Universal ABC Kit and DAB peroxidase substrate kits 
(Vector Laboratories, Burlingame, CA, USA) per the manufacturers protocol. All sections were counter-stained 
with nuclear fast red or haematoxylin.
FISH Analysis. Dual-color FISH was performed on serial sections. Slides were de-paraffinized by three treat-
ments in xylene and then dehydrated in 100% ethanol. Slides were prepared for pepsin treatment following man-
ufacturer’s instructions from DAKO (Histology Kit, K5599). DAKO pepsin was added at approximately 200 μ l 
per slide. Slides were heated to 37 °C for 10 min on Hybridizer (Abbott Molecular, Thermobrite) with lid open 
using fixed temperature program. The slides were then washed in 2 × SSC, and dehydrated in an ethanol series 
and allowed to dry. The chromosome paints were obtained as previously described by chromosome flow sorting33, 
followed by degenerate oligonucleotide primed PCR amplification34. The flow sorted probes were labeled with 
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biotin-16-dUTP and digoxigenin-dUTP. In situ hybridizations of the probes were performed using 5 μ l concen-
trations of biotin labeled probe and DIG labeled probe. The mixture was precipitated and dissolved in 14 μ l of 
hybridization buffer (formamide 50%, dextran sulfate 10%, 2× SSC). The probe was denatured at 80 °C for 10 min 
and reannealed at 37 °C for 90 min before hybridization. The previously prepared slide was denatured in 70% for-
mamide/2× SSC, at 65 °C for 80 sec, and quenched in an ice-cold 70% ethanol followed by dehydration in a room 
temperature 70%, 90%, and 100% ethanol series. Hybridization was carried out in a humidity chamber at 37 °C 
overnight. Slides were washed and counterstained with diamidino-2-phenylindole (DAPI) (0.8 ng/μ l) for 10 min 
and the slides were mounted with antifade. Analyses were performed under an Axioplan 2 (Zeiss) fluorescence 
microscope coupled with a CCD camera (Photometrics), and images were captured with FISHview 4.5 software 
(Applied Spectral Imaging Inc., Vista, CA).
DNA Isolation and PCR. DNA was isolated from wild type mouse tail tissue, LacZ+ mouse tail tissue, LA-7 
rat cells, and mammary tissues using Qiagen DNeasy Blood and Tissue kit (cat # 69506 Qiagen; Valencia, CA, USA). 
PCR detection was performed using the following primers: SRY primers: 5′ -GCTGGGATGCAGGTGGAAAA 
and 5′  -CCCTCCGATGAGGCTGATATT. LacZ primers: 5′  -GGATACTGACGAAACGCCTGCC 
and 5′  -GATCCGCGCTGGCTACCGGC; rat actin: 5′ -GGCTTTAGGAGCTTGACAATACTG and 
5′ -GCATTGGTCACCTTTAGATGGA; Control primers to chromosome 1 were previously described35.
The amplified products were visualized on a 2% agarose gel containing 500 ng/mL ethidium bromide and 
illuminated under ultraviolet light. Water served as a negative loading control.
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